News Headlines

  1. New Partnership Brings Next-Generation Cell Isolation Solutions To Researchers Advancing Cell And Gene Therapy Development 9/25/2025

    Cayman Chemical, a global provider of life science research tools, and Akadeum Life Sciences, a leader in buoyancy-based cell separation technology, announced today a distribution partnership to expand access to Akadeum's next-generation cell isolation technology for cell and gene therapy development.

  2. Verismo Therapeutics Announces Partnership With Miltenyi Biotec To Support Advancing Clinical Programs 9/25/2025

    Verismo Therapeutics, a clinical-stage CAR T company developing a novel KIR-CAR platform technology, today announced the successful manufacture of its first clinical cell product using lentiviral vector supplied by Miltenyi Bioindustry, a dedicated CDMO division of Miltenyi Biotec.

  3. Bora Biologics To Manufacture NYPOZI At San Diego Facility In Partnership With InvaGen Pharmaceuticals, A Cipla Group Company 9/25/2025

    Bora Biologics, a leading contract development and manufacturing organization (CDMO) specializing in biologics, proudly announces its partnership with InvaGen Pharmaceuticals Inc., a wholly owned subsidiary of Cipla Limited, for the manufacture of NYPOZI (biosimilar to Neupogen) at its FDA-registered facility in San Diego, California.

  4. WuXi Biologics Launches WuXia™4.0, Targeted Integration Cell Line Platform TrueSite TI™ To Accelerate Biologics Development With High Titer And Superior Stability 9/25/2025

    WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced the launch of TrueSite TI™, an industry-leading targeted integration (TI)-based CHO cell line platform designed to reshape biologics development by accelerating timelines, enhancing product quality, and ensuring consistent scalability for antibody and complex protein therapies.

  5. ITM And TerThera Sign Supply Agreement For Medical Radioisotope Terbium-161 9/24/2025

    ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, and TerThera BV, a leading provider of GMP-grade Terbium-161, today announced a supply agreement for non-carrier-added (n.c.a.) Terbium-161 (Tb-161), a novel medical radioisotope with distinct chemical properties and emerging potential in radiopharmaceutical therapy.

  6. Leading CDMO Enhances cGMP Lab Infrastructure To Strengthen Position 9/24/2025

    The Ritedose Corporation is investing more than $17 million to further its in-house cGMP laboratory capabilities by expanding its analytical chemistry and microbiology laboratories.

  7. Dr. Park CDMO Selects Thermo Fisher Scientific To Equip New Viral Vector Manufacturing Facility 9/24/2025

    Thermo Fisher Scientific Inc., the world leader in serving science, today announced that Dr. Park, an emerging viral vector contract development and manufacturing organization (CDMO) based in South Korea, has selected Thermo Fisher to provide advanced bioreactors and consumables for its newest facility.

  8. Hovione And Microinnova Partner To Advance Modular Flow Chemistry For Multi-Purpose Manufacturing 9/24/2025

    Hovione, an international integrated pharmaceutical development and manufacturing organization, and Microinnova Engineering, a recognized leader in continuous process intensification, today announced a partnership to advance the development of multi-purpose, plug-and-play modular equipment for flow chemistry.

  9. Launch Of The Next Syringe Production Line 9/23/2025
  10. Wisconsin's Nuclear Medicine Corridor Accelerates Cancer Treatment Breakthroughs 9/23/2025

    A stretch of southern Wisconsin has developed into a significant hub for nuclear medicine innovation, combining breakthrough cancer research with the industrial infrastructure to manufacture and scale life-saving treatments.